Background:
Weight loss appears to be an effective method for primary prevention of hypertension. However, the long-term effects of weight loss on blood pressure have not been extensively studied.
Objective:
To present detailed results from the weight loss arm of Trials of Hypertension Prevention (TOHP) II.
Design:
Multicenter, randomized clinical trial testing the efficacy of lifestyle interventions for reducing blood pressure over 3 to 4 years. Participants in TOHP II were randomly assigned to one of four groups. This report focuses only on participants assigned to the weight loss (n = 595) and usual care control (n = 596) groups.
Patients:
Men and women 30 to 54 years of age who had nonmedicated diastolic blood pressure of 83 to 89 mm Hg and systolic blood pressure less than 140 mm Hg and were 110% to 165% of their ideal body weight at baseline.
Intervention:
The weight loss intervention included a 3-year program of group meetings and individual counseling focused on dietary change, physical activity, and social support.
Measurements:
Weight and blood pressure data were collected every 6 months by staff who were blinded to treatment assignment.
Results:
Mean weight change from baseline in the intervention group was −4.4 kg at 6 months, −2.0 kg at 18 months, and −0.2 kg at 36 months. Mean weight change in the control group at the same time points was 0.1, 0.7, and 1.8 kg. Blood pressure was significantly lower in the intervention group than in the control group at 6, 18, and 36 months. The risk ratio for hypertension in the intervention group was 0.58 (95% CI, 0.36 to 0.94) at 6 months, 0.78 (CI, 0.62 to 1.00) at 18 months, and 0.81 (CI, 0.70 to 0.95) at 36 months. In subgroup analyses, intervention participants who lost at least 4.5 kg at 6 months and maintained this weight reduction for the next 30 months had the greatest reduction in blood pressure and a relative risk for hypertension of 0.35 (CI, 0.20 to 0.59).
Conclusions:
Clinically significant long-term reductions in blood pressure and reduced risk for hypertension can be achieved with even modest weight loss.
References
- 1.
Burt VL ,Whelton P ,Roccella EJ ,Brown C ,Cutler JA ,Higgins M ,et al . Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-13. CrossrefMedlineGoogle Scholar - 2.
- 3.
Stamler J ,Stamler R ,Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615. CrossrefMedlineGoogle Scholar - 4.
Collins R ,Peto R ,MacMahon S ,Hebert P ,Fiebach NH ,Eberlen KA ,et al . Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet. 1990;335:827-38. CrossrefMedlineGoogle Scholar - 5.
Hebert PR ,Moser M ,Mayer J ,Glynn RJ ,Hennekens CH . Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578-81. CrossrefMedlineGoogle Scholar - 6.
Reisin E ,Frohlich ED ,Messerli FH ,Dreslinski GR ,Dunn FG ,Jones MM ,et al . Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98:315-9. LinkGoogle Scholar - 7.
Langford HG ,Blaufox MD ,Oberman A ,Hawkins CM ,Curb JD ,Cutter GR ,et al . Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA. 1985;253:657-64. CrossrefMedlineGoogle Scholar - 8.
Stamler R ,Stamler J ,Grimm R ,Gosch FC ,Elmer P ,Dyer A ,et al . Nutritional therapy for high blood pressure. Final report of a four-year randomized, controlled trial—the Hypertension Control Program. JAMA. 1987;257:1484-91. CrossrefMedlineGoogle Scholar - 9.
Corrigan SA ,Raczynski JM ,Swencionis C ,Jennings SG . Weight reduction in the prevention and treatment of hypertension: a review of representative clinical trials. Am J Health Promot. 1991;5:208-14. CrossrefMedlineGoogle Scholar - 10.
Stamler R ,Stamler J ,Gosch FC ,Civinelli J ,Fishman J ,McKeever P ,et al . Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial. JAMA. 1989;262:1801-7. CrossrefMedlineGoogle Scholar - 11.
- 12.
- 13.
MacMahon S ,Cutler J ,Brittain E ,Higgins M . Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 1987;8Suppl B 57-70. CrossrefMedlineGoogle Scholar - 14.
Cutler JA . Randomized clinical trials of weight reduction in nonhypertensive persons. Ann Epidemiol. 1991;1:363-70. CrossrefMedlineGoogle Scholar - 15.
Stevens VJ ,Corrigan SA ,Obarzanek E ,Bernauer E ,Cook NR ,Hebert P ,et al . Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med. 1993;153:849-58. CrossrefMedlineGoogle Scholar - 16.
Hebert PR ,Bolt RJ ,Borhani NO ,Cook NR ,Cohen JD ,Cutler JA ,et al . Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995;5:130-9. CrossrefMedlineGoogle Scholar - 17.
- 18.
- 19.
Hollis JF ,Satterfield S ,Smith F ,Fouad M ,Allender PS ,Borhani N ,et al . Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995;5:140-8. CrossrefMedlineGoogle Scholar - 20.
Appel LJ ,Hebert PR ,Cohen JD ,Obarzanek E ,Yamamoto M ,Buring J ,et al . Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995;5:149-55. CrossrefMedlineGoogle Scholar - 21.
Wright BM ,Dore CF . A random-zero sphygmomanometer. Lancet. 1970;1:337-8. MedlineGoogle Scholar - 22.
Lasser VI ,Raczynski JM ,Stevens VJ ,Mattfeldt-Beman MK ,Kumanyika S ,Evans M ,et al . Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epide-miol. 1995;5:156-64. CrossrefMedlineGoogle Scholar - 23.
Suppl 2 51S-209S. MedlineGoogle Scholar - 24.
Meltzer AA ,Everhart JE . Correlations with self-reported weight loss in overweight U.S. adults. Obes Res. 1996;4:479-86. CrossrefMedlineGoogle Scholar - 25.
Kumanyaka SK ,Obarzanek E ,Stevens VJ ,Hebert PR ,Whelton PK . Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr. 1991;53:1631S-1638S. CrossrefMedlineGoogle Scholar - 26.
Wadden TA ,Foster GD ,Wang J ,Pierson RN ,Yang MU ,Moreland K ,et al . Clinical correlates of short- and long-term weight loss. Am J Clin Nutr. 1992;56:271S-274S. CrossrefMedlineGoogle Scholar - 27.
Fitzwater SL ,Weinsier RL ,Wooldridge NH ,Birch R ,Liu C ,Bartolucci AA . Evaluation of long-term weight changes after a multidisciplinary weight control program. J Am Diet Assoc. 1991;91:421-6, 429. CrossrefMedlineGoogle Scholar - 28.
Perri MG ,Sears SF ,Clark JE . Strategies for improving maintenance of weight loss. Toward a continuous care model of obesity management. Diabetes Care. 1993;16:200-9. CrossrefMedlineGoogle Scholar - 29.
Perri MG ,Nezu AM ,Patti ET ,McCann KP . Effect of length of treatment on weight loss. Journal of Consulting and Clinical Psychology. 1989;57:450-2. CrossrefMedlineGoogle Scholar - 30.
- 31.
Wing RR ,Jeffery RW ,Hellerstedt WL . A prospective study of effects of weight cycling on cardiovascular risk factors. Arch Intern Med. 1995;155:1416-22. CrossrefMedlineGoogle Scholar
Author, Article, and Disclosure Information
From Kaiser Permanente Center for Health Research, Portland, Oregon; National Heart, Lung, and Blood Institute, Bethesda, Maryland; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland; University of Alabama, Birmingham, Alabama; University of Pittsburgh, Pittsburgh, Pennsylvania; St. Louis University School of Medicine, St. Louis, Missouri;
University of California School of Medicine, Davis, California; University of Tennessee, Memphis, Tennessee; and University of Medicine and Dentistry of New Jersey, Newark, New Jersey.
Grant Support: Phase II of the Trials of Hypertension Prevention was supported by cooperative agreements HL37852, HL37924, HL37907, HL37904, HL37854, HL37849, HL37884, HL37853, HL37899, and HL37906 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Corresponding Author: Victor J. Stevens, PhD, Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227; e-mail, victor.
Current Author Addresses: Dr. Stevens: Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227.
Dr. Obarzanek: National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 8136, Bethesda, MD 20892-7936.
Drs. Cook and Lee: Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215.
Dr. Appel: Welch Center, Johns Hopkins University, 2024 East Monument Street, Suite 2-645, Baltimore, MD 21205-2223.
Dr. Smith West and Ms. Bragg: Division of Preventive Medicine, University of Alabama, 1717 11th Avenue South, 700 Medical Tower Building, Birmingham, AL 35294.
Ms. Milas: University of Pittsburgh, 130 North Bellefield Avenue, Fourth Floor, Pittsburgh, PA 15260.
Dr. Mattefeldt-Beman: Department of Nutrition and Dietetics, St. Louis University, 3437 Caroline Street, St. Louis, MO 63104.
Ms. Belden and Ms. Millstone: University of California, Davis, One Shields Avenue, Davis, CA 95616.
Dr. Raczynski: University of Alabama, 1717 11th Avenue, 401 Medical Tower Building, Birmingham, AL 35294.
Ms. Brewer: University of Tennessee, 756 Ridge Lake Boulevard, Suite 205, Memphis, TN 38120.
Ms. Singh: Preventive Cardiology Program, University of Medicine and Dentistry of New Jersey, Stanley S. Bergen Building, GB20, 65 Bergen Street, Newark, NJ 07107-3001.
Dr. Cohen: Preventive Cardiology, St. Louis University, 3525 Caroline Avenue, St. Louis, MO 63104.
Author Contributions: Conception and design: V.J. Stevens, E. Obarzanek, L.J. Appel, M. Mattefeldt-Beman, M. Millstone, J. Raczynski, A. Brewer, J. Cohen.
Analysis and interpretation of the data: V.J. Stevens, E. Obarzanek, N.R. Cook, I.-M. Lee, L.J. Appel, D. Smith West, C.N. Milas, M. Mattefeldt-Beman, M. Millstone, J. Raczynski, J. Cohen.
Drafting of the article: V.J. Stevens, E. Obarzanek, N.R. Cook, D. Smith West, M. Mattefeldt-Beman, B. Singh.
Critical revision of the article for important intellectual content: V.J. Stevens, E. Obarzanek, N. Cook, I.-M. Lee, L.J. Appel, D. Smith West, M. Mattefeldt-Beman, J. Raczynski.
Final approval of the article: V.J. Stevens, E. Obarzanek, N. Cook, I.-M. Lee, L.J. Appel, M. Mattefeldt-Beman, L. Belden, C. Bragg, M. Millstone, A. Brewer, J. Cohen.
Provision of study materials or patients: V.J. Stevens, L.J. Appel, M. Mattefeldt-Beman, L. Belden, C. Bragg.
Statistical expertise: N.R. Cook, I.-M. Lee.
Obtaining of funding: V.J. Stevens, M. Mattefeldt-Beman, J. Cohen.
Administrative, technical, or logistic support: V.J. Stevens, M. Mattefeldt-Beman, L. Belden.
Collection and assembly of data: V.J. Stevens, L.J. Appel, M. Mattefeldt-Beman, L. Belden, M. Millstone, B. Singh.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.